Pepgen: Funding, Investors & Team (Aug 2026)
PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and they are advancing novel conjugate therapeutics to the clinic.
Pepgen has raised $113M across 1 funding round on record, the most recent an undisclosed round of $113M announced in Aug 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pepgen Company Profile and Key Stats
Latest funding round on record: Aug 2021.
Pepgen Funding Rounds
Pepgen Founders and Leadership Team
Contact details for the Pepgen team: 1 of 1 has an email address on file.
Start 14-day free trial →Pepgen Funding Compared to Other Biotechnology Startups
Pepgen's latest round of $113M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pepgen in Biotechnology and Oxford
Companies Similar to Pepgen
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Pepgen Funding FAQs
What does Pepgen do?
PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and they are advancing novel conjugate therapeutics to the clinic.
How much funding has Pepgen raised?
Pepgen has raised $113M across 1 round on record. The most recent is an undisclosed round of $113M announced in Aug 2021.
When did Pepgen last raise funding?
Pepgen's most recent funding round on record is an undisclosed round of $113M, announced in Aug 2021.
Who is the CEO of Pepgen?
James McArthur is listed as CEO at Pepgen.
Where is Pepgen headquartered?
Pepgen is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Pepgen have?
Pepgen is in the 11-50 employee band.
How does Pepgen's funding compare to other Biotechnology startups?
Pepgen's latest round of $113M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Pepgen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pepgen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.